EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

A Novel Atherogenic Index Is Associated with Multivessel Coronary Disease in Patients Undergoing Invasive Coronary Angiography: A Cross-Sectional Retrospective Study

Víctor Vallejo-García, María del Carmen León del Pino, Victoria Jacas-Osborn, Francisco José Ferrer Sargues, Noemí Valtueña-Gimeno, Óscar Fabregat-Andrés

Journal of Clinical Medicine · 11.11.2026 · 15 (22) · 8802

DOI: 10.3390/jcm15228802 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.11.2026. Verfasst von Víctor Vallejo-García und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Católica de Valencia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Multivessel coronary artery disease (MVCD) determines prognosis and revascularization strategy. The CRP × 100/HDL-C atherogenic index (AtI) integrates systemic inflammation and anti-atherogenic lipoprotein parameters. We evaluated its capacity to predict MVCD in patients undergoing invasive coronary angiography (CA). Materials and Methods: Retrospective cross-sectional study of a cohort of 204 patients with suspected ischemic heart disease. The 173 patients who underwent invasive CA as a diagnostic test were classified as having no significant lesions (n = 55), single-vessel disease (n = 69), or MVCD (n = 49). The new AtI was measured as CRP (mg/dL) × 100/HDL-C (mg/dL). Kruskal-Wallis with Bonferroni correction, ROC analysis with DeLong confidence intervals, adjusted logistic regression (log2-transformed), and Harrell bootstrap optimism correction (1000 iterations) were applied.

Results

The AtI showed a progressive gradient: median 0.73 (IQR 0.57–1) in the no-lesions group, 1.71 (IQR 0.95–2.44) in the single-vessel group, and 2.86 (IQR 1.79–6.67) in the MVCD group (Kruskal-Wallis p < 0.001), Spearman ρ = 0.596 (p < 0.001), and all Bonferroni-corrected pairwise comparisons significant. AUC for MVCD prediction: 0.818 (95% CI 0.753–0.883), superior to Castelli I (0.685; DeLong p = 0.003), Castelli II (0.626; p < 0.001), and the plasma atherogenic index (0.708; p = 0.013). At cut-off ≥2.00 (Youden criterion): sensitivity 73.5%, specificity 78.2%, NPV 88.2%. The AtI was independently associated with MVCD in adjusted logistic regression (OR 2.84 per doubling; 95% CI 1.95–4.13; p < 0.001). Adding the AtI to a classical risk factor model increased AUC from 0.652 to 0.836 (ΔAUC +0.184; 95% CI 0.093–0.275; p < 0.001; optimism-corrected AUC 0.812).

Conclusions

The CRP × 100/HDL-C AtI is independently associated with MVCD and adds discrimination to a clinical model. It is a simple and inexpensive marker of angiographic extent; a cut-off of ≥2 had an NPV of 88.2% (86.5% after optimism correction), and its clinical usefulness requires external and prospective validation.

Förderung

  • Universidad Católica de Valencia

Zitieren

APA

Vallejo-García, V., Pino, M. D. C. L. D., Jacas-Osborn, V., Sargues, F. J. F., Valtueña-Gimeno, N., & Fabregat-Andrés, Ó. (2026). A Novel Atherogenic Index Is Associated with Multivessel Coronary Disease in Patients Undergoing Invasive Coronary Angiography: A Cross-Sectional Retrospective Study. Journal of Clinical Medicine, 15(22), 8802. https://doi.org/10.3390/jcm15228802

Vancouver

Vallejo-García V, Pino MDCLD, Jacas-Osborn V, Sargues FJF, Valtueña-Gimeno N, Fabregat-Andrés Ó. A Novel Atherogenic Index Is Associated with Multivessel Coronary Disease in Patients Undergoing Invasive Coronary Angiography: A Cross-Sectional Retrospective Study. Journal of Clinical Medicine. 2026;15(22):8802. doi:10.3390/jcm15228802

BibTeX
@article{VallejoGarca2026,
  author = {Vallejo-García, Víctor and Pino, María del Carmen León del and Jacas-Osborn, Victoria and Sargues, Francisco José Ferrer and Valtueña-Gimeno, Noemí and Fabregat-Andrés, Óscar},
  title = {A Novel Atherogenic Index Is Associated with Multivessel Coronary Disease in Patients Undergoing Invasive Coronary Angiography: A Cross-Sectional Retrospective Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {8802},
  doi = {10.3390/jcm15228802}
}
Kostenlos starten →